| Net Cash Provided by (Used in) Operating Activities |
$594,267,000 |
USD |
-74% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$464,286,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$40,228,000 |
USD |
-95% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
87,016,604 |
shares |
0.18% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$89,753,000 |
USD |
42% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$220,334,000 |
USD |
17% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$169,504,000 |
USD |
18% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$134,897,000 |
USD |
32% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
22,400,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
22,400,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$169,504,000 |
USD |
18% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$712,809,000 |
USD |
12% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |